re: Ann: FDA agrees on potential regulatory p... Good news is that they will be rolling up another indication for Omapro which will increase the potential market significantly.
Not just for T315I mutation but also failure to multiple TKIs.
Ann: FDA agrees on potential regulatory pathway f, page-3
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)